Literature DB >> 9547932

Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers.

S L Frederick1, V I Reus, D Ginsberg, S M Hall, R F Munoz, G Ellman.   

Abstract

BACKGROUND: Glucocorticoids have been linked to self-administration of a wide range of drugs in animals and are increased endogenously by chronic nicotine intake. Corticosteroids have also been shown to regulate nicotine receptor sensitivity and to be involved in behavioral sensitization to nicotine.
METHODS: Cortisol levels and cortisol suppression in response to dexamethasone were measured in a sample of smokers participating in a smoking cessation treatment trial.
RESULTS: Cortisol levels dropped significantly during the early quitting process (2 weeks post-quit) and returned to a level below baseline 1 month post-quit. The magnitude of the initial drop in cortisol was strongly related to post-quit distress and marginally predictive of abstinence. Neither baseline nor post-quit changes in percent cortisol suppression after dexamethasone were related to abstinence success or withdrawal distress.
CONCLUSIONS: Withdrawal from cigarette smoking is marked by a reduction in cortisol levels that appears to be related to the degree of distress experienced during the early quitting period. Further work is needed to determine whether withdrawal-related cortisol changes or distress are predictive of abstinence success.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9547932     DOI: 10.1016/S0006-3223(97)00423-X

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  20 in total

Review 1.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

2.  Enhanced pain perception prior to smoking cessation is associated with early relapse.

Authors:  Motohiro Nakajima; Mustafa al'Absi
Journal:  Biol Psychol       Date:  2011-08-02       Impact factor: 3.251

3.  Lifestyle, stress and cortisol response: Review II : Lifestyle.

Authors:  S Fukuda; K Morimoto
Journal:  Environ Health Prev Med       Date:  2001-04       Impact factor: 3.674

Review 4.  Biological mechanisms underlying the relationship between stress and smoking: state of the science and directions for future work.

Authors:  Jessica M Richards; Brooke A Stipelman; Marina A Bornovalova; Stacey B Daughters; Rajita Sinha; C W Lejuez
Journal:  Biol Psychol       Date:  2011-07-07       Impact factor: 3.251

5.  Biologic Commonalities between Mental Illness and Addiction.

Authors:  Karen J Hartwell; Bryan K Tolliver; Kathleen T Brady
Journal:  Prim psychiatry       Date:  2009-08-01

6.  Circulating orexin changes during withdrawal are associated with nicotine craving and risk for smoking relapse.

Authors:  Mustafa al'Absi; Andrine Lemieux; James S Hodges; Sharon Allen
Journal:  Addict Biol       Date:  2018-08-16       Impact factor: 4.280

7.  Stress decreases the ability to resist smoking and potentiates smoking intensity and reward.

Authors:  Sherry A McKee; Rajita Sinha; Andrea H Weinberger; Mehmet Sofuoglu; Emily L R Harrison; Meaghan Lavery; Jesse Wanzer
Journal:  J Psychopharmacol       Date:  2010-09-03       Impact factor: 4.153

8.  Hair cortisol as a biomarker of stress in mindfulness training for smokers.

Authors:  Simon B Goldberg; Alison R Manley; Stevens S Smith; Jeffrey M Greeson; Evan Russell; Stan Van Uum; Gideon Koren; James M Davis
Journal:  J Altern Complement Med       Date:  2014-06-25       Impact factor: 2.579

9.  Patterns of cortisol and craving by menstrual phase in women attempting to quit smoking.

Authors:  Alicia M Allen; Sharon S Allen; Jennifer Widenmier; Mustafa Al'absi
Journal:  Addict Behav       Date:  2009-03-31       Impact factor: 3.913

10.  Contribution of hypothalamic-pituitary-adrenal activity and environmental stress to vulnerability for smoking in adolescents.

Authors:  Uma Rao; Constance L Hammen; Edythe D London; Russell E Poland
Journal:  Neuropsychopharmacology       Date:  2009-08-19       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.